>>> US Research Calls I

Research Calls I
  • Upgrades
    • 4D Molecular Therapeutics (FDMT) upgraded to Equal Weight from Underweight at Morgan Stanley
    • ArcelorMittal (MT) upgraded to Overweight from Neutral at JPMorgan
    • ASML (ASML) upgraded to Buy from Neutral at Rothschild & Co Redburn
    • Aurinia Pharmaceuticals (AUPH) upgraded to Buy from Hold at Jefferies, tgt $21
    • Black Hills (BKH) upgraded to Outperform from Sector Perform at Scotiabank, tgt $81
    • Champion Homes (SKY) upgraded to Outperform from Neutral at Zelman, tgt $79.25
    • Datadog (DDOG) upgraded to Overweight from Sector Weight at KeyBanc, tgt $230
    • Expedia (EXPE) upgraded to Neutral from Underweight at Piper Sandler, tgt $250
    • First Northwest Bancorp (FNWB) upgraded to Overweight from Neutral at Piper Sandler, tgt $13.50
    • Globus Medical (GMED) upgraded to Buy from Neutral at BofA Securities, tgt $91
    • Globus Medical (GMED) upgraded to Buy from Hold at Truist, tgt $93
    • Host Hotels (HST) upgraded to Buy from Neutral at Compass Point, tgt $22
    • JFrog (FROG) upgraded to Outperform from Perform at Oppenheimer, tgt $75
    • Matson (MATX) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $142
    • Middleby (MIDD) upgraded to Neutral from Underweight at JPMorgan, tgt $125
    • Penn Entertainment (PENN) upgraded to Buy from Hold at CBRE, tgt $18
    • Penn Entertainment (PENN) upgraded to Buy from Hold at Stifel, tgt $21
    • TC Energy (TRP) upgraded to Outperform from Market Perform at BMO Capital
    • The Trade Desk (TTD) upgraded to Buy from Hold at Benchmark, tgt $65
    • Unity Software (U) upgraded to Outperform from Neutral at Macquarie, tgt $50
  • Downgrades
    • AbCellera Biologics (ABCL) downgraded to Market Perform from Outperform at Leerink, tgt $4
    • Americold Realty Trust (COLD) downgraded to In Line from Outperform at Evercore ISI, tgt $13
    • BlackLine (BL) downgraded to Neutral from Outperform at Robert W. Baird, tgt $55
    • CarMax (KMX) downgraded to Sector Perform from Outperform at RBC Capital
    • Cogent Communications (CCOI) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $27
    • DENTSPLY SIRONA (XRAY) downgraded to Market Perform from Outperform at William Blair
    • Intellia Therapeutics (NTLA) downgraded to Underweight from Neutral at JPMorgan, tgt $5
    • Penn Entertainment (PENN) downgraded to Hold from Buy at Needham
    • Sangamo BioSciences (SGMO) downgraded to Equal Weight from Overweight at Barclays, tgt $1
    • Sweetgreen (SG) downgraded to Market Perform from Outperform at William Blair
    • Teads Holding (TEAD) downgraded to Market Perform from Outperform at Citizens JMP
    • Treace Medical Concepts (TMCI) downgraded to Neutral from Buy at BTIG
    • Treace Medical Concepts (TMCI) downgraded to Underweight from Neutral at JPMorgan, tgt $5
  • Others
    • Aardvark Therapeutics (AARD) initiated with a Buy at BTIG, tgt $26
    • ConnectOne Bancorp (CNOB) assumed with an Overweight at Piper Sandler, tgt $28
    • Foghorn Therapeutics (FHTX) initiated with a Buy at Guggenheim, tgt $12
    • Immunic (IMUX) initiated with a Buy at Roth Capital, tgt $3